286 related articles for article (PubMed ID: 31954716)
1. Pathway analysis of glutamate-mediated, calcium-related signaling in glioma progression.
Pei Z; Lee KC; Khan A; Erisnor G; Wang HY
Biochem Pharmacol; 2020 Jun; 176():113814. PubMed ID: 31954716
[TBL] [Abstract][Full Text] [Related]
2. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.
Lange F; Hörnschemeyer J; Kirschstein T
Cells; 2021 May; 10(5):. PubMed ID: 34067762
[TBL] [Abstract][Full Text] [Related]
3. Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.
Altinoz MA; Elmaci İ
Nitric Oxide; 2018 Sep; 79():68-83. PubMed ID: 29030124
[TBL] [Abstract][Full Text] [Related]
4. Autocrine glutamate signaling promotes glioma cell invasion.
Lyons SA; Chung WJ; Weaver AK; Ogunrinu T; Sontheimer H
Cancer Res; 2007 Oct; 67(19):9463-71. PubMed ID: 17909056
[TBL] [Abstract][Full Text] [Related]
5. Attenuated AMPA receptor expression allows glioblastoma cell survival in glutamate-rich environment.
van Vuurden DG; Yazdani M; Bosma I; Broekhuizen AJ; Postma TJ; Heimans JJ; van der Valk P; Aronica E; Tannous BA; Würdinger T; Kaspers GJ; Cloos J
PLoS One; 2009 Jun; 4(6):e5953. PubMed ID: 19536293
[TBL] [Abstract][Full Text] [Related]
6. Altered glutamatergic and inflammatory pathways promote glioblastoma growth, invasion, and seizures: An overview.
Feyissa AM; Rosenfeld SS; Quiñones-Hinojosa A
J Neurol Sci; 2022 Dec; 443():120488. PubMed ID: 36368135
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic N-methyl-D-aspartate receptor activation inhibits neurotransmitter release through nitric oxide formation in rat hippocampal nerve terminals.
Sequeira SM; Malva JO; Carvalho AP; Carvalho CM
Brain Res Mol Brain Res; 2001 Apr; 89(1-2):111-8. PubMed ID: 11311981
[TBL] [Abstract][Full Text] [Related]
8. Excitation-transcription coupling via calcium/calmodulin-dependent protein kinase/ERK1/2 signaling mediates the coordinate induction of VGLUT2 and Narp triggered by a prolonged increase in glutamatergic synaptic activity.
Doyle S; Pyndiah S; De Gois S; Erickson JD
J Biol Chem; 2010 May; 285(19):14366-76. PubMed ID: 20212045
[TBL] [Abstract][Full Text] [Related]
9. GL261 glioma tumor cells respond to ATP with an intracellular calcium rise and glutamate release.
Strong AD; Indart MC; Hill NR; Daniels RL
Mol Cell Biochem; 2018 Sep; 446(1-2):53-62. PubMed ID: 29318454
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of NMDA and AMPA glutamate receptors elicits distinct concentration dynamics of nitric oxide in rat hippocampal slices.
Frade JG; Barbosa RM; Laranjinha J
Hippocampus; 2009 Jul; 19(7):603-11. PubMed ID: 19115375
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
[TBL] [Abstract][Full Text] [Related]
12. Dissection of mitogenic and neurodegenerative actions of cystine and glutamate in malignant gliomas.
Savaskan NE; Seufert S; Hauke J; Tränkle C; Eyüpoglu IY; Hahnen E
Oncogene; 2011 Jan; 30(1):43-53. PubMed ID: 20802520
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells.
Oh MC; Kim JM; Safaee M; Kaur G; Sun MZ; Kaur R; Celli A; Mauro TM; Parsa AT
PLoS One; 2012; 7(10):e47846. PubMed ID: 23110111
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional modulation of calcium-permeable AMPA receptor subunits in glioblastoma by MEK-ERK1/2 inhibitors and their role in invasion.
Ramaswamy P; Dalavaikodihalli Nanjaiah N; Prasad C; Goswami K
Cell Biol Int; 2020 Mar; 44(3):830-837. PubMed ID: 31814223
[TBL] [Abstract][Full Text] [Related]
15. Glutamate Receptors and Glioblastoma Multiforme: An Old "Route" for New Perspectives.
Corsi L; Mescola A; Alessandrini A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30978987
[TBL] [Abstract][Full Text] [Related]
16. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
17. NOS Expression and NO Function in Glioma and Implications for Patient Therapies.
Tran AN; Boyd NH; Walker K; Hjelmeland AB
Antioxid Redox Signal; 2017 Jun; 26(17):986-999. PubMed ID: 27411305
[TBL] [Abstract][Full Text] [Related]
18. Chronic hyperammonemia impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo.
Hermenegildo C; Montoliu C; Llansola M; Muñoz MD; Gaztelu JM; Miñana MD; Felipo V
Eur J Neurosci; 1998 Oct; 10(10):3201-9. PubMed ID: 9786213
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of Chuk-Me-Sun-Dan on NMDA- and AMPA-evoked nitric oxide synthase activity in mouse brain.
Koo BS; Choi EG; Park JB; Cho CH; Chung KH; Kim CH
Immunopharmacol Immunotoxicol; 2005; 27(3):499-514. PubMed ID: 16237959
[TBL] [Abstract][Full Text] [Related]
20. Monoamines in glioblastoma: complex biology with therapeutic potential.
Caragher SP; Hall RR; Ahsan R; Ahmed AU
Neuro Oncol; 2018 Jul; 20(8):1014-1025. PubMed ID: 29126252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
